drugset / Trial / NCT01172236

Supplementation With Lactoferrin in Preterm Newborns

NCT01172236

Phase 4 Completed 1300 enrolled University of Siena
NaSingle-groupOpen-labelTreatment

Summary

The main objective of the study is to evaluate the antioxidant effect of lactoferrin and its ability to reduce free radicals related diseases in the newborn. This evaluation will be done through the assessment of neuro-developmental follow-up. The secondary objective is to identify a panel of markers for assessing oxidative stress and for a correlation with the lactoferrin antioxidant effect.

Timeline

Start
2011-01
Primary completion
2012-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactoferrin Protein / enzyme biologic 100 mg